Stalicla completes phase 1b trials into precision medicine for autism spectrum disorder
STP1 has demonstrated good safety and tolerability profiles, while also showing positive results for neurological function
Read More
Tag: autism
Gov’t reveals new strategy to improve support and care for autistic people
The Autism Strategy will be backed by nearly £75m in the first year, which includes £40m through the NHS Long Term Plan
Read More
EU regulators approve Novartis’ breast cancer combo
Piqray in combination with fulvestrant is the first treatment for tumours with a PIK3CA mutation
Read More
Vulnerable children stuck in mental health hospitals for too long
Too many children are being admitted to secure hospitals unnecessarily, and in some cases are spending months and years of their childhood in institutions.
Read More
Major study again rejects that vaccinations cause autism
A new study has found “no increased risk for autism after MMR vaccination”.
Read More
GW’s cannabinoid fails in focal seizures trial
A mid-stage trial assessing an experimental cannabinoid being developed by GW Pharma for adults with focal seizures has failed to hit key targets.
Read More
Breakthrough status for Roche’s autism drug
Roche’s balovaptan has picked up a Breakthrough Therapy Designation in the US for its potential as a treatment for people with autism spectrum disorder (ASD), potentially placing the drug on a faster path to market.
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
